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KetofolAbstract Objective: The rapid emergence and recovery from sevoﬂurane anesthesia is associated
with a high incidence of emergence agitation in children, ranging up to 80% (Yan-lin and Hong-bo,
2010). Both ketofol and dexmedetomidine have been shown to successfully reduce the incidence and
severity of EA, if administered at the end of sevoﬂurane anesthesia. However, it was not determined
which agent has better efﬁcacy. The purpose of this study was to compare the effectiveness of keto-
fol and dexmedetomidine, given 10 min before the end of surgery, in preventing EA.
Patients and methods: Ninety pediatric patients, aged 3–6 years old, American Society of Anesthe-
siologists I or II, and undergoing orthopedic surgeries under sevoﬂurane-based anesthesia were
recruited into the study. They were randomly assigned to one of three equal groups: Group K,
received ketofol (ketamine 0.25 mg/kg and propofol 1 mg/kg); Group D, received dexmedetomidine
0.3 lg/kg and Group C, received 0.9% normal saline. The study drugs were given 10 min before the
end of surgery. In postanesthesia care unit, incidence of EA was evaluated with Aono’s four point
scale and the severity of EA was assessed using Paediatric Anesthesia Emergence Delirium scale
upon awakening (T0), after 10 min (T10), 20 min (T20), and 30 min (T30). Extubation time, emer-
gence time and time of ﬁrst analgesic requirement were also recorded.
Results: There were no signiﬁcant differences in demographic data, duration of surgery or sevoﬂu-
rane exposure among the three groups. The incidence of EA in group K and group D was similar
and signiﬁcantly lower than that in group C at T0, T10, and T20. The incidence of EA decreased
signiﬁcantly over time in all groups. The severity of EA was signiﬁcantly lower in groups K and D
than in group C at T0, T10 and T20. Time to extubation and to get modiﬁed Aldrete scoreP9 was
signiﬁcantly longer in group D than that in group K. In comparison to control group, group K had
longer extubation time and time to get modiﬁed Aldrete score P9. The time of ﬁrst analgesic
requirement was signiﬁcantly longer in group K than that of group D. Both groups K and D
provided better analgesic effect in early postoperative period when compared to control group.522558.
278 W.A. Ali et al.Conclusion: We found that ketofol in a dose (propofol 1 mg/kg in a combination with ketamine
0.25 mg/kg) was as effective as dexmedetomidine in a dose of 0.3 lg/kg for prevention of EA,
but with better analgesic effect and without delaying of emergence.
 2016 Publishing services by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Sevoﬂurane is widely used in pediatric anesthesia because of a
fast and well tolerated inhaled induction, low cardiodepressive
effect and hepatotoxicity, hemodynamic stability and rapid
recovery from anesthesia. However, the occurrence of EA in
children after sevoﬂurane anesthesia is common, with a
reported incidence up to 80% [1]. Although EA is a self-
limited adverse event, it can cause injury to the child or to
the surgical site and may also lead to the accidental removal
of surgical dressings, intravenous catheters and drains; and
extra nursing care may be necessary. So, several strategies
should be carried out to prevent this distressing scenario. Phar-
macological prevention of EA relies on analgesic and/or seda-
tive agents.
Dexmedetomidine is a more highly speciﬁc a2-
adrenoceptor agonist (a2/a1 = 1620/1) than clonidine (a2/
a1 = 220/1), and has sedative and analgesic properties without
signiﬁcant respiratory depression at clinical dosages [2].
Dexmedetomidine is reported to signiﬁcantly reduce EA fre-
quency after sevoﬂurane anesthesia in pediatric surgery and
non-surgical procedures in inpatient and outpatient settings
[3,4].
Propofol is a non-opioid, non-barbiturate, sedative-
hypnotic agent with rapid onset and short duration of action
[5]. It showed an overall protective effect against EA, when
given as continuous administration or as a bolus dose at the
end of anesthesia [6]. Ketamine is a phencyclidine derivative,
classiﬁed as a dissociative sedative that provides analgesia
and amnesia. It was also found that ketamine administration
is effective in preventing EA [7]. However, it is associated with
signiﬁcant adverse effects, including frightening emergence
reactions, sympathomimetic effects and vomiting when admin-
istered in sedating doses. Combining low-dose ketamine with
propofol (ketofol) has been used extensively as a part of pro-
cedural sedation and analgesia in the emergency department.
The complementary effects of this combination are supposed
to produce lower toxicity compared to each drug alone
through decreasing required doses [8]. We hypothesized that
ketofol can be as effective as dexmedetomidine in prevention
of EA due to its combined sedative and analgesic properties.
So, we designed this study to compare the efﬁcacy of ketofol
and dexmedetomidine in reducing the incidence of EA in
children.2. Patients and methods
This study was carried out in El-Minia University Hospital
during the period from April 2014 to March 2015 after institu-
tional ethics committee approval and informed consents
obtained from all patients’ parents prior to entry into the
study. It involved 90 children of both sexes, aged 3–6 years
old, ASA I or II scheduled to undergo orthopedic surgeryunder sevoﬂurane anesthesia. Patients with known allergy to
any of the drugs used, with developmental delay, psychologi-
cal, or neurological disorders, or with a history of chronic or
acute intake of any sedative and analgesic drugs were
excluded.
A careful medical history was taken from the parents.
Then, general examination including (Heart rate, Blood Pres-
sure, Respiratory rate) and physical examination including
(chest, heart and abdomen) were done and complete blood pic-
ture was checked pre-operatively. Children were randomly
allocated into 3 equal groups (30 children each) by means of
random numbers generated by a computer:
Group K: received ketofol (ketamine 0.25 mg/kg and propo-
fol 1.0 mg/kg in combination diluted to a volume of 10 ml
by addition of normal saline), 10 min before the end of
surgery.
Group D: received dexmedetomidine (0.3 mcg/kg diluted in
normal saline to a volume of 10 ml), 10 min before the end
of surgery.
Group C: received normal saline (10 ml), 10 min before the
end of surgery (control group).
Children were fasted for 6 h without solid food and for 3 h
without clear liquids and no premedication was given. Upon
arrival into the operating room, induction of anesthesia started
by inhalation of sevoﬂurane 8% in 100% O2 which was main-
tained till loss of consciousness. During induction of anesthe-
sia, an electrocardiogram, pulse oximeter and noninvasive
ABP monitor were attached.
After obtaining a sufﬁcient depth of anesthesia, a periph-
eral intravenous line was inserted and fentanyl 2 lg/kg and
atracurium 0.5 mg/kg were administered to facilitate endotra-
cheal intubation. Direct laryngoscopy was performed and the
trachea was intubated with an appropriate sized tube.
Anesthesia was maintained with 100% O2 and sevoﬂurane
2–2.5 vol.% while mechanical ventilation was performed to
sustain end tidal CO2 at 30–35 mmHg. Intraoperatively, HR,
MAP, and SPO2 were recorded at the following measurement
times i.e. preinduction, at induction, preintubation, postintu-
bation, 5 min postintubation, every 10 min during the surgery,
postextubation and then every 10 min for half an hour.
Increase in HR and/or MAP >20% than baseline values
was treated with incremental doses of fentanyl 1–2 mcg/kg.
Ten minutes before the completion of the procedure, the
study drugs were administered to the patients by an anesthetist
not involved in the study. Children in group K were given keto-
fol (ketamine 0.25 mg/kg and propofol 1.0 mg/kg in combina-
tion in 10 ml saline); those in group D were given
dexmedetomidine (0.3 mcg/kg in 10 ml saline) while those in
group C received normal saline (10 ml). After closure, sevoﬂu-
rane anesthesia was discontinued and manual ventilation was
performed with 100% O2. Residual muscle relaxation was
reversed using neostigmine 0.05 mg/kg and atropine 0.02 mg/kg.
Table 2 Objective Pain Scale (OPS).
Parameter Finding Points
Systolic blood
pressure
Increase <20% of preoperative blood
pressure
0
Increase 20–30% of preoperative blood
pressure
1
Increase >30% of preoperative blood
pressure
2
Crying Not crying 0
Responds to age appropriate nurturing
(tender loving care)
1
Does not respond to nurturing 2
Movements No movements relaxed 0
Restless moving about in bed constantly 1
Thrashing (moving wildly) 2
Rigid (stiﬀ) 2
Agitation Asleep or calm 0
Can be comforted to lessen the agitation
(mild)
1
Cannot be comforted (hysterical) 2
Complains of
pain
Asleep 0
States no pain 0
Cannot localize 1
Localizes pain 2
Table 3 Modiﬁed Aldrete scoring system.
Assessment items Condition Grade
Activity, able to move,
voluntarily or on command
4 extremities 2
2 extremities 1
No 0
Breathing Able to breathe deeply
& cough freely
2
Dyspnea, shallow or
limited breathing
1
Apnea 0
Consciousness Fully awake 2
Arousable on calling 1
Unresponsive 0
Circulation (BP) ±20% of pre-
anesthesia level
2
±20% to 49% of pre- 1
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reﬂex was restored, and regular spontaneous breathing was
achieved. The time from sevoﬂurane discontinuation to the
removal of ETT was recorded and deﬁned as the extubation
time. The duration of surgery and duration of sevoﬂurane
exposure (from mask induction to the discontinuation of the
inhaled anesthetic) were also recorded. Then children were
transferred to the post-anesthesia care unit (PACU) and one
of their parents accompanied them at the PACU until
discharge.
In PACU, the incidence of EA was assessed using AONO’s
4-point scale [9]. AONO’s scale was graded as follows:
1 = calm; 2 = not calm but could be easily consoled;
3 = moderately agitated or restless and not easily calmed;
and 4 = combative, excited, or disoriented, thrashing around.
Scores of one and two were considered as the absence of EA,
and scores of three and four were analyzed as the presence of
EA. The severity of EA was evaluated using pediatric anesthe-
sia emergence delirium (PAED) scale devised by Sikich and
Lerman [10] (Table 1), a ﬁve-point rating scale with ﬁve grades
for each item. The incidence and severity of EA were recorded
upon awakening i.e. when the child had the ﬁrst response to
command or eye opening on command (T0), and every
10 min thereafter during the ﬁrst 30 min (T10, T20 and T30).
In case of agitation in the PACU, the ﬁrst action is to encour-
age parental contact and when this failed midazolam 0.05–
0.1 mg/kg was administered intravenously.
Objective pain scale [11] (Table 2) was evaluated every
10 min. When patients had OPS P5, they were given supple-
mental analgesics (paracetamol 15 mg/kg and/or diclofenac
1 mg/kg) and time from anesthetic discontinuation till 1st anal-
gesic requirement was recorded.
During PACU stay, MAP, HR and SpO2 were continu-
ously monitored. MAP and HR were recorded upon arrival
to the PACU, every 10 min and on PACU discharge. If oxygen
saturation fell below 90%, oxygen face mask was given to the
child.
Modiﬁed Aldrete score [12] (Table 3) was evaluated and
adopted as the discharge criteria according to which a score
P9 is needed for discharge from PACU. The time from anes-
thetic discontinuation to attainment of this score was recorded.
Children were discharged from the PACU to the ward when
the required score was achieved without agitation, pain or
vomiting.Table 1 Pediatric anesthesia emergence delirium (PAED)
scale.
Behavior Not
at
all
Just
a
little
Quite
a bit
Very
much
Extremely
The child makes eye
contact with the
caregiver
4 3 2 1 0
The child’s actions are
purposeful
4 3 2 1 0
The child is aware of
his/her surroundings
4 3 2 1 0
The child is restless 0 1 2 3 4
The child is
inconsolable
0 1 2 3 4
anesthesia level
±50% of pre-
anesthesia level
0
SPO2 Maintains SpO2 >92%
in ambient air
2
Maintain SpO2 >90%
with O2
1
Maintain SpO2 <90%
with O2
02.1. Statistical analysis
Data entry and analysis were all done with I.B.M. compatible
computer using software called SPSS for windows version 11.
Graphics was done using Excel. Quantitative data were
Table 5 Incidence of emergence agitation at T0, T10, T20 and
T30 in the study groups.
Agitation Group K
N= 30
Group D
N= 30
Group C
N= 30
T0 8 (26.7%)# 5 (16.7%)y 27 (90%)#,y
T10 3 (10%)# 3 (10%)y 18 (60%)#,y
T20 0 (0%) 0 (0%) 5 (16.7%)#,y
T30 0 (0%) 0 (0%) 0 (0%)
* P< 0.05 K vs. D groups.
# P< 0.05 K vs. C groups.
y P< 0.05 D vs. C groups.
280 W.A. Ali et al.presented by mean and standard deviation and qualitative data
were presented as frequency distribution.
2.1.1. Significance tests
– Chi square test: for categorical data.
– Kruskal wallis test: for nonparametric quantitative data.
– One way ANOVA test: for parametric quantitative data
inside the group.
Based on the previously published studies [3,13], the sample
size was calculated to detect 40% difference in the incidence of
agitation between study and control groups with power of 0.80
a signiﬁcance level of 0.05. Calculating for a 10% drop-out
rate, 30 patients in each group were appropriate to detect this
difference with any degree of conﬁdence.
3. Results
This prospective, randomized, and double-blinded study
included 90 pediatric patients, undergoing orthopedic surgery
under sevoﬂurane anesthesia. Patients were randomized into
3 equal groups (30 patients each, K, D, and C groups).
There were no signiﬁcant differences in age, weight, sex dis-
tribution, ASA physical status, duration of surgery, or dura-
tion of sevoﬂurane administration among the 3 groups
(Table 4).
The incidence of EA in group K and group D was similar
and signiﬁcantly lower than that in group C at T0, T10, and
T20. At 30 min after emergence, none of the patients had
EA. Upon awakening, EA occurred in 26%, 16% and 90%
of patients in groups K, D and C respectively. Over time,
the incidence of EA decreased to be 10% in ketofol and
dexmedetomidine groups and 60% in control group at T10.
At T20, none of the patients in groups k and D developed
EA while it occurred in 16.7% in control group (Table 5).
Regarding the severity of EA, the mean values of PAED
score in group K (10.1 ± 0.35, 9.3 ± 1.15, 7 ± 0) and in
group D (10 ± 0.25, 9.1 ± 0.57, and 6.9 ± 0.57) at T0, T10,
T20 respectively were signiﬁcantly lower than the correspond-
ing values in control group (15.2 ± 0.8, 12 ± 1.3, 9 ± 0)
(Table 6). There was no signiﬁcant differences between ketofol
and dexmedetomidine group at any time during assessment.
Time to extubation was signiﬁcantly longer in dexmedeto-
midine group than that in ketofol group (12.8 ± 1.95 min. inTable 4 Demographic and anesthetic data of the study groups.
Demographic data Group K
N= 30
Age (years):
Mean ± SD
4.2 ± 1.5
Gender (Male/Female) 17/13
Weight (kg):
Mean ± SD
16.7 ± 4.02
ASA (I/II) 19/11
Operative time (min):
Mean ± SD
43.5 ± 11.8
Sevoﬂurane duration (min)
Mean ± SD
58.5 ± 6.2group D versus 9.08 ± 1.7 min. in group K, p< 0.001). When
compared to control group, both of study drugs (Ketofol and
dexmedetomidine), showed signiﬁcantly longer extubation
times. (Table 7). Patients in dexmedetomidine group had more
sedation score as shown by the longer time to get modiﬁed
Alderete score P9 (17.1 ± 2.5 min.) compared to ketofol
(p< 0.001) and control (p< 0.001). Ketofol group took
longer time to get modiﬁed Alderet scoreP9 than that of con-
trol group. (Table 7). Ketofol provided more effective analge-
sia in the early postoperative period than dexmedetomidine
where time of 1st analgesic requirement was signiﬁcantly
longer in group K than that of group D (91.58 ± 12.2 min
in group K versus 34.1 ± 6 min in group D, p< 0.001). Both
ketofol and dexmedetomidine provided more prolonged anal-
gesia when compared to control group (9.2 ± 2.4 min in group
C, p< 0.001) (Table 7).
As regard heart rate and mean arterial pressure (MAP),
they decreased after induction in all groups with no signiﬁcant
differences among them or signiﬁcant differences when com-
pared to baseline values. Also, there was no signiﬁcant differ-
ences between the readings among the 3 groups throughout the
surgery till extubation time. After tracheal extubation, the
pressor response of extubation was more evident in control
group, where HR and MAP were signiﬁcantly higher than
the corresponding values in ketofol and dexmedetomidine
groups at postextubation and 10 min later. Also, the hemody-
namic variables recorded postextubation and 10 min later were
signiﬁcantly higher in group K than group D. Within each
group, HR and MAP values did not change signiﬁcantly from
baseline ones at any time during the study (Figs. 1 and 2). Con-
cerning SpO2, there was no signiﬁcant changes in the readingsGroup D
N= 30
Group C
N= 30
4.3 ± 1.58 4.5 ± 1.76
19/11 20/10
17.5 ± 3.5 16.9 ± 3.8
21/9 22/8
43.2 ± 11.8 45.1 ± 12.4
59.2 ± 6.8 61.18 ± 10.3
Table 6 PAED score (Mean ± SD) at T0, T10, T20 and T30
of the study groups.
PAED score
Mean ± SD
Group K
N= 30
Group D
N= 30
Group C
N= 30
T0 10.1 ± 0.35 # 10 ± 0.25y 15.2 ± 0.8 #,y
T10 9.3 ± 1.15 # 9.1 ± 0.57y 12 ± 1.3 #,y
T20 7 ± 0# 6.9 ± 0.57 y 9 ± 0 #,y
T30 4.9 ± 0.57 4.86 ± .53 5 ± 1
*P< 0.05 K vs. D groups.
# P< 0.05 K vs. C groups.
y P< 0.05 D vs. C groups.
Table 7 Recovery characteristics of the study groups.
Group K
N= 30
Group D
N= 30
Group C
N= 30
Extubation time
(min)
Mean ± SD
9.08 ± 1.7*,# 12.8 ± 1.95*,y 4.7 ± 1.6#,y
Time to modiﬁed
Aldrete score P9:
(min)
Mean ± SD
14.2 ± 2.1*,# 17.1 ± 2.5*,y 9.2 ± 2.4#,y
Time of 1st
analgesic
requirement (min)
Mean ± SD
91.58 ± 12.2*,# 34.1 ± 6*,y 9.2 ± 2.4#,y
* P< 0.05 K vs. D groups.
# P< 0.05 K vs. C groups.
y P< 0.05 D vs. C groups.
Dexmedetomidine versus ketofol effect 281among the 3 groups or when compared to baseline values
within each group throughout the surgery and recovery period.
4. Discussion
EA is a troublesome clinical phenomenon of uncertain etiol-
ogy. The incidence of EA varies from 2% to 80% [6] and
depends on the hypnotic agent used {incidence increases withFigure 1 Mean heart rate changes (bthe new fast-acting and less soluble volatile agents named
sevoﬂurane and desﬂurane compared to halothane or isoﬂu-
rane [14].
Prevention of EA depends mainly on reducing preoperative
anxiety, removing postoperative pain and administration of
sedative and/or analgesic agents. Many studies focused on
the pharmacologic preventive strategies against emergence agi-
tation and found several drugs efﬁcient in the prevention of
this adverse event. These preventive treatments included
propofol given at the end of surgery [6] or by continuous
administration during surgery [15]; intraoperative fentanyl
[6]; ketamine [16]; clonidine [17]; dexmedetomidine [3,18,19];
preoperative gabapentin[20]; midazolam [17]; intraoperative
magnesium infusion [21]; preoperative midazolam [22] and
intraoperative dexamethasone [23].
The researches in the ﬁeld of emergence agitation usually
compare these preventive treatments to ﬁnd the most efﬁcient
agents in this indication with minimal side effects.
To our knowledge, this is the ﬁrst study comparing the
effects of dexmedetomidine and ketofol in prevention of EA
in children under sevoﬂurane anesthesia. We found that keto-
fol was as effective as dexmedetomidine in preventing EA
where incidence of ED in both groups (K and D) was similar
and signiﬁcantly lower than that in control group. Ketofol
provided better analgesic effect with earlier recovery, when
compared to control and dexmedetomidine groups.
Dexmedetomidine, a highly selective alpha 2 adrenoceptor
agonist, is of great interest in prevention of EA due to its seda-
tive and analgesic effects. Several studies proved its efﬁcacy in
reducing the incidence of postanesthesia agitation in children
by 57–70% compared with control groups [3,24–28]. Consis-
tent with Guler’s study [24], dexmedetomidine group showed
longer time to extubation and discharge from PACU than in
ketofol and control groups. Other studies did not demonstrate
prolongation of emergence or discharge time [3,25,26]. This
difference may be due to variable dosing, route or timing of
administration of dexmedetomidine.
Regarding the effectiveness of propofol in prevention of
EA, propofol given as an induction bolus showed no efﬁciency
in decreasing ED occurrence [6]. This is probably related to its
short half-life way out which makes its blood and effect site
concentration below its therapeutic effect at recovery from
anesthesia. Several studies have suggested that a singleeat/min) among the study groups.
Figure 2 Changes in mean arterial blood pressure (mmHg) among the study groups.
282 W.A. Ali et al.administration of 1 mg/kg of propofol at the discontinuation
of anesthesia is effective in reducing EA without delay of
discharge from the PACU in children receiving sevoﬂurane
for induction and maintenance of anesthesia. The decreased
incidence of EA could be accounted for the residual sedative
effect and euphoric effect of propofol in the early recovery
period [29].
Aouad et al. reported that the administration of 1 mg/kg
propofol at the end of surgery in children, undergoing strabis-
mus surgery, signiﬁcantly decreased the incidence of EA
(19.5% compared to 47.2% in the placebo group). Recovery
time was increased in the propofol group compared to the pla-
cebo group [30]. In our study, ketofol group also showed
longer extubation time and delayed discharge from PACU
when compared to control group. Abu-Shahwan’s study
showed that the administration of subhypnotic doses of propo-
fol (1 mg/kg) at the end of sevoﬂurane general anesthesia was
effective in decreasing the incidence and severity of EA in chil-
dren undergoing MRI (4.8% incidence of EA in propofol
group compared to 26.8% in the placebo group [31]. Com-
pared to the Aouad study, this better outcome can be attribu-
ted to setting the PAED acceptable score at 16 and the
nonpainful nature of MRI. On the other hand, another study
found that administration of propofol 1 mg/kg at the end of
surgery did not have any signiﬁcant effect in reducing the inci-
dence and severity of EA in children (aged 3–8 years), under-
going adenotonsillectomy under sevoﬂurane anesthesia [32].
They explained failure of propofol to prevent EA in their
research because the surgery in their study (adenotonsillec-
tomy) was different from that in Aouad‘s (strabismus surgery).
Although the surgery type itself that involves the tonsil, middle
ear, and eye is a major factor for inducing EA, adenotonsillec-
tomy is the more important independent risk factor for EA
than strabismus surgery [33]. Eckenhoff et al. speculated that
sense of suffocation during emergence from anesthesia may
contribute to EA in patients undergoing head and neck surgery
[34].
Ketamine has been used successfully to reduce the incidence
and severity of EA, when given in small doses (0.25 mg/kg) at
the end of MRI procedures and dental repair surgery under
sevoﬂurane anesthesia [35,36]. Lee and colleagues conﬁrmed
the effectiveness of small doses of ketamine (0.25 and0.5 mg/kg), given 10 min. before the end of surgery in decreas-
ing the incidence of EA compared to control group in children,
undergoing adenotonsillectomy [16]. There were no signiﬁcant
differences in extubation time, time to discharge from PACU
or PONV between the three groups but the K 0.5 group
showed a lower pain score than K 0.25 group. In our study,
we chose the smaller dose of ketamine (0.25 mg/kg) in combi-
nation with propofol (ketofol) to avoid excessive delay in
emergence or PACU discharge time. The added effects of keta-
mine and propofol prolonged extubation and PACU discharge
time compared to the control group.
In comparison with ketamine, dexmedetomidine was com-
parable in reducing the incidence of EA and pain after
sevoﬂurane anesthesia for pediatric strabismus surgery [19].
Incidence of POV was lower in dexmedetomidine group
(15%) than in Ketamine (44%) or placebo (45.8%) groups.
Awakening time and time to discharge from PACU were
longer in dexmedetomidine and ketamine groups than in pla-
cebo group. On the contrary, another trial failed to show any
beneﬁcial effects of ketamine (0.25 mg/kg) or midazolam
(0.03 mg/kg), given before end of surgery, for the prevention
of EA in children undergoing abdominal and genital surgery,
compared to placebo [37]. The authors explained that paren-
tal presence in the PACU and good pain relief with caudal
block resulted in satisfactory PAED scores (610) in the 3
groups.
Ketofol (ketamine in combination with propofol) has been
used for procedural sedation in children and it was found that
low-dose ketamine effectively offsets the cardiorespiratory
depression caused by propofol while providing adequate seda-
tion and analgesia [38]. Ketamine in low-dose has been used
successfully to prevent recurrence of EA in subsequent anes-
thetic sessions in seven children, anesthetized with prolonged
propofol total intravenous anesthesia for radiation therapy
[39]. Another study showed that ketofol was as effective as
propofol in the prevention of EA in children undergoing ade-
noidectomy or adenotonsillectomy under sevoﬂurane anesthe-
sia. In addition, ketofol had superior analgesic effect
demonstrated by lower OPS on arrival to PACU and 10 and
20 min. later, when compared to propofol and control groups
[40]. Similarly, our data proved the comparable efﬁcacy of
ketofol to dexmedetomidine in preventing EA. However, it
Dexmedetomidine versus ketofol effect 283had better analgesic effect, when compared to dexmedeto-
midine and control groups.
Concerning the hemodynamic effects of the study drugs,
MAP and HR decreased after induction in all groups but this
reduction was clinically acceptable (±20% of baseline values)
and did not need any pharmacological intervention. The only
signiﬁcant changes in hemodynamics occurred postextubation,
where MAP and HR were signiﬁcantly lower in ketofol and
dexmedetomidine groups than those of control group postextu-
bation and 10 min. later. This could be attributed to the exagger-
ated pressor response in the control group and higher incidence
and severity of EA in the early recovery period in control group
compared to ketofol and dexmedetomidine groups.
Throughout the study, hemodynamics within each group
did not change signiﬁcantly compared to baseline values at
any time either after administration of the study drugs or after
extubation. This may be due to use of small doses of the study
drugs.
In children, large doses of dexmedetomidine cause periph-
eral vasoconstriction, which may lead to transient systemic
hypertension whereas low doses cause central sympatholysis,
which can lead to systemic hypotension. In healthy children,
the severity of hypotension varies directly with the dose of
dexmedetomidine. When a loading dose between 0.5 and
1 lg/kg dexmedetomidine is administered over 10 min as the
sole sedative, systolic BP decreases as the dose increases, reach-
ing a maximum decrease of 30% from baseline at 1 lg/kg [41].
When a small loading dose of 0.5 lg/kg dexmedetomidine is
infused over 5 min during 1 minimum alveolar concentration
sevoﬂurane and desﬂurane, systolic BP decreases only 10%
[2]. In our study, we used 0.3 lg/kg dexmedetomidine for the
prevention of EA. This small dose seemed to maintain the
hemodynamic stability throughout the study. Similarly, addi-
tion of low-dose ketamine to propofol preserved MAP without
prolonging recovery or increasing the incidence of adverse
events in children, undergoing cardiac catheterization, lumbar
puncture and bone marrow aspiration [38,42].
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